Epoch Investment Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Epoch Investment Partners's CELG Position: Q1 2018 in Review
Epoch Investment Partners sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 76,608 shares — an estimated $8M sold.
Epoch Investment Partners first reported a position in CELG in Q4 2015 and held it in 9 quarters. The position peaked at $14M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.
- Epoch Investment Partners reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
- Epoch Investment Partners sold 76,608 Celgene Corp shares in Q1 2018, an estimated $8M.
- Epoch Investment Partners first reported a position in Celgene Corp in Q4 2015 and held it in 9 quarters.
- Epoch Investment Partners's Celgene Corp position peaked at $14M in Q3 2017.
- 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.
Based on Epoch Investment Partners's 13F filing for Q1 2018, filed 14 May 2018.